The Enterprise Value as of June 2026 (TTM) for Aurinia Pharmaceuticals Inc. (AUPH) is 2.06B

According to Aurinia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.06B. This represents a change of 20.35% compared to the average of 1.71B of the last 4 quarters.

Aurinia Pharmaceuticals Inc. (AUPH) Historical Enterprise Value (quarterly & annually)

How has AUPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Aurinia Pharmaceuticals Inc. over the last ten years is 1.17B. The current 2.06B Enterprise Value has changed 17.57% with respect to the historical average. Over the past ten years (40 quarters), AUPH's Enterprise Value was at its highest in in the December 2021 quarter at 2.80B. The Enterprise Value was at its lowest in in the December 2016 quarter at 79.38M.

Aurinia Pharmaceuticals Inc. (AUPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aurinia Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aurinia Pharmaceuticals Inc. (AUPH) Average Enterprise Value

How has AUPH Enterprise Value performed in the past?

The current Enterprise Value of Aurinia Pharmaceuticals Inc. (AUPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aurinia Pharmaceuticals Inc. (AUPH) Enterprise Value vs. Peers

How is AUPH’s Enterprise Value compared to its peers?

Aurinia Pharmaceuticals Inc.’s Enterprise Value is greater than MannKind Corporation (1.51B), greater than Harmony Biosciences Holdings, Inc. (1.61B), greater than Nuvation Bio Inc. (1.59B), greater than Celldex Therapeutics, Inc. (2.05B), greater than Janux Therapeutics, Inc. (796.69M), less than Vera Therapeutics, Inc. (2.42B), greater than AbCellera Biologics Inc. (1.66B), greater than Biohaven Ltd. (1.21B), greater than Stoke Therapeutics, Inc. (1.71B), greater than Immunocore Holdings plc (1.06B),

Build a custom stock screener for Aurinia Pharmaceuticals Inc. (AUPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurinia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aurinia Pharmaceuticals Inc. (AUPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aurinia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.